Low or high magnesium concentration in intermittent warm blood cardioplegia in patients undergoing coronary artery surgery: a prospective randomised study

ISRCTN ISRCTN95530505
DOI https://doi.org/10.1186/ISRCTN95530505
Secondary identifying numbers PG/02/044/13713
Submission date
23/04/2002
Registration date
23/04/2002
Last edited
07/06/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Massimo Caputo
Scientific

Bristol Heart Institute
Bristol Royal Infirmary
Marlborough Street
Bristol
BS2 8HW
United Kingdom

Phone +44 (0)117 9283145
Email massimocaputo@hotmail.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesA comparison between two diferent strategies of myocardial protection.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedIschaemic heart disease
InterventionPatients will be randomised to:
1. 5 mmol/l Magnesium (Mg2+)
2. 16 mmol/l Mg2+)
In the intermittent antegrade warm blood cardioplegia
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Magnesium
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/12/2001
Completion date01/12/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants400 adult patients
Key inclusion criteria1. A diagnosis of ischaemic heart disease
2. Undergoing primary myocardial revascularisation with the use of cardiopulmonary bypass and cardioplegic arrest
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/12/2001
Date of final enrolment01/12/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Bristol Heart Institute
Bristol
BS2 8HW
United Kingdom

Sponsor information

British Heart Foundation (UK)
Charity

14 Fitzhardinge Street
London
W1H 6DH
United Kingdom

Phone +44 (0)20 7935 0185
Email research@bhf.org.uk
Website http://www.bhf.org.uk/
ROR logo "ROR" https://ror.org/02wdwnk04

Funders

Funder type

Charity

British Heart Foundation (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
the_bhf, The British Heart Foundation, BHF
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2011 Yes No